Table 1 BCL2 and ROR1 expression in SCLC IHC samples.
From: Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung
BCL2 Status | ROR1 Status | Total | |
|---|---|---|---|
Positive | Negative | ||
Positive | 45 (83.36%) | 3 (5.36%) | 48 (85.71%) |
Negative | 7 (12.50%) | 1 (1.79%) | 8 (14.29%) |
Total | 52 (92.86%) | 4 (7.14%) | |
